Although these models provided crucial evidence for revealing the ‘melatonin-BMAL1-ALDH3A1’ regulatory axis, the applicability of this mechanism in triple-negative breast cancer (TNBC) still needs further verification. Here, BMAL1 is linked to triple-negative breast carcinoma.